NRG-DT001 phase Ib trial of neoadjuvant navtemadlin (previously AMG232 and KRT232) concurrent with preoperative radiotherapy in wild-type p53 soft tissue sarcoma of the extremity and body wall. Meeting Abstract

cited authors

  • Welliver, Meng Xu; Torres-Saavedra, Pedro A.; Van Tine, Brian Andrew; Kirsch, David G.; Rudek, Michelle A.; Wakely, Paul; Schwartz, Gary K.; Pollock, Raphael E.; Kane, John Michael; Jiang, Steve B.; Rogers, Alan D.; Houghton, Peter; Batus, Marta; Johnston, Andrea Lea; Spraker, Matthew; Howell, Krisha; Harris, Jonathan; Wang, Dian

authors

Publication Date

  • June 1, 2022

webpage

published in

category

volume

  • 40

issue

  • 16